gabexate has been researched along with Hematemesis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Hematemesis: Vomiting of blood that is either fresh bright red, or older coffee-ground in character. It generally indicates bleeding of the UPPER GASTROINTESTINAL TRACT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hama, Y | 1 |
| Iwasaki, Y | 1 |
| Kaji, T | 1 |
| Hatsuse, K | 1 |
| Kusano, S | 1 |
1 other study available for gabexate and Hematemesis
| Article | Year |
|---|---|
Coil compaction after embolization of the superior mesenteric artery pseudoaneurysm.
Topics: Acute Disease; Aneurysm, False; Embolization, Therapeutic; Gabexate; Hematemesis; Humans; Male; Mese | 2002 |